2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
生物活性
Description
In Vivo
In Vitro
化合物的使用
Kinase Assay
Cell Assay
Animal Administration
参考文献
BMS309403 is orally active, reducing atherosclerosis in mice lacking apoplipoprotein E.It also protects against the development of insulin resistance associated with genetic or diet-induced obesity in mice.FABP4 dose-dependently suppresses the release of MCP-1 from macrophages. For the detailed information of BMS-309403, the solubility of BMS-309403 in water, the solubility of BMS-309403 in DMSO, the solubility of BMS-309403 in PBS buffer, the animal experiment (test) of BMS-309403, the cell expriment (test) of BMS-309403, the in vivo, in vitro and clinical trial test of BMS-309403, the EC50, IC50,and affinity,of BMS-309403, For the detailed information of BMS-309403, the solubility of BMS-309403 in water, the solubility of BMS-309403 in DMSO, the solubility of BMS-309403 in PBS buffer, the animal experiment (test) of BMS-309403, the cell expriment (test) of BMS-309403, the in vivo, in vitro and clinical trial test of BMS-309403, the EC50, IC50,and affinity,of BMS-309403, Please contact DC Chemicals.
